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Summary
 Background In HDR brachytherapy precision of catheter implantation is crucial for confor-
mal treatment planning as a starting point for better optimization process.
 Aim The aim was to investigate differences between virtual and real needle position 
and the effect of needle displacement on dosimetric parameters as a function of 
prostate volume for better evaluation of “real” implant with respect to ﬁ nal dose 
distribution.
 Materials/Methods Thirty treatment plans calculated by Nucletron SWIFT™ were randomly select-
ed. Dosimetric data including V100 for prostate gland and D10 for urethra were 
analyzed as a function of prostate volume and needle displacement.
  Needle displacement was determined by measuring the distance between virtu-
al and real positions of respective needles in three sectional images: at the base, 
apex of the prostate gland and reference image. Dosimetric parameters were de-
termined for consecutive computer plans: virtual (before implantation), live (af-
ter implantation and renewed optimization). For the purpose of this study a new 
parameter, VD (Volume-Dose), was created.
 Results VD indicates the quality of “real” dose distribution with respect to “virtual” treat-
ment plan. In order to realize the assumption of virtual plan (VD<1) for a given 
prostate volume, mean values of needle displacement r should not exceed racceptable  
according to the formula: racceptable(Vp) μ Vp
2. For larger glands (above 30cc) ﬁ nal 
dose distribution is less dependent on needle displacement than smaller ones.
 Conclusions The experiment determined maximum values of needle displacement for a giv-
en Vp parameter, allowing one to take advantage of optimization algorithms and 
to improve the ﬁ nal dose distribution.
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BACKGROUND
High dose rate brachytherapy has become an in-
credibly popular method for early-stage prostate 
cancer [1–3]. In HDR remote afterloading tech-
nique the source is positioned inside the cathe-
ters in predeﬁ ned dwell positions. Moreover, the 
dwell times (time of source stopovers) inside the 
catheter are individually selected (optimized) 
for better targeting of the volume of interest as 
well as sparing normal tissue and organs at risks 
[4–6]. Additionally, increasingly improved imag-
ing techniques facilitate accurate implantation. 
“Real-time” HDR brachytherapy based on tran-
srectal ultrasound guidance provides continuous 
visualization of the prostate during the treatment 
planning process [1].
However, in brachytherapy, precision of cathe-
ter implantation according to pre-planned nee-
dle position and patient’s anatomy is crucial 
for conformal treatment planning and in HDR 
“stepping source” technique is a starting point 
for better optimization process. There is a lack 
of reports in the literature on the subject of nee-
dle displacement as the distance between pre-
planned catheter position and its real one after 
implantation, and its impact on the ﬁ nal dose 
distribution.
AIM
The aim of this study was to analyze the needle 
displacement as a function of prostate volume 
and provide precautions for the needle inser-
tion procedure to improve the quality of the ﬁ -
nal dose distribution.
MATERIALS AND METHODS 
In the Centre of Oncology – MSC Memorial 
Institute Branch Gliwice patients with early stage 
localized prostate carcinoma (T1–T2) were treat-
ed with combined external beam therapy and 
HDR192 Ir brachytherapy from 2003. Interstitial 
brachytherapy of the prostate is delivered as a 
boost during a single treatment session. Treatment 
plans are based on transrectal ultrasound imaging 
and calculated with the Nucletron Swift™ treat-
ment planning system, which was designed for 
“real time” conformal brachytherapy.
On the basis of the transverse US images, tak-
en with 1 mm scan thickness, volumes of inter-
est such as PTV and organ at risk (urethra) are 
reconstructed. According to 3D VOI contours a 
“virtual” implant is prepared. Positions of the nee-
dles are established with coordinates of the tem-
plate holes. Dwell positions in each catheter and 
dwell weights are determined in order to realize 
the optimal treatment plan. This “virtual” plan 
(Figure 1A) is evaluated with parameters of the 
dose volume histogram V100 and D10, which de-
ﬁ ne respectively: the volume of prostate covered 
by 100% isodose surface, and the dose value that 
is delivered to 10% volume of the urethra.
The implantation procedure is visualized on the 
live US images, which allow one to control “live” 
needle placement according to its virtual coor-
dinates. Insertion of needles always begins with 
upper right horizontally and ends with lower left 
corner of the template.
Even small differences between prescribed nee-
dle position and the real one result in changes in 
the virtual dose distribution. Therefore, on the 
basis of real implant geometry, dwell times are 
recalculated to obtain the ﬁ nal dose distribution 
(“live” treatment plan) (Figure 1B). The quality 
of the “live” plan is also evaluated with dosimet-
ric parameters V100 and D10.
In this study thirty treatment plans (“virtual” and 
“live” calculated for each patient) were randomly 
selected for analysis. For each treatment plan differ-
ences between “virtual” and “real” dose distribution 
caused by needle displacement were estimated by 
the new parameter VD (Volume – Dose) (eq. 1)
VD =
 V100 virtual . D10 live (1)
V100 live     D10 virtual
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V100 virtual and V100 live are fractions of the prostate 
volume that are encompassed by 100% isodose 
in the “virtual” and “real” treatment plan, while 
D10 virtual and D10 live are dose values that encom-
passed 10% volume of the urethra in the “virtu-
al” and “live” treatment plan respectively.
Values of the provided VD formula, which was 
created for the purpose of our analysis, charac-
terize the ﬁ nal dose distribution with regard to 
the virtual plan:
When:
a.  VD<1 – “real” dose distribution is considered 
to be better than virtual one for prostate gland 
and/or urethra,
b.  VD>1 – worsening in “real” dose distribution 
for prostate gland and/or urethra when com-
pared to “virtual” plan,
c.  VD=1 – “virtual” and “real” treatment plans are 
considered to be equivalent.
VD parameter was also designed to compare the 
differences between “real” and “virtual” treatment 
plans as a function of needle displacement and 
prostate volume.
Needle displacement was determined by measur-
ing the distance between “virtual” and “real” po-
sitions of respective needles (Figure 2) in three 
axial images (Figure 3) acquired at the base and 
the apex of the gland and in the reference image. 
Mean values of needle displacement were calculat-
ed for each plane and for three planes in total.
RESULTS
Needle number, needle displacement and 
prostate volume
Number of implanted needles varied from 12 
to 18 for single “real” treatment plan and the 
Figure 1. “Real-time” conformal treatment planning for HDR brachytherapy of prostate cancer. (A) “virtual” treatment plan before 
implantation based on pre-planned catheter coordinates and anatomy-based optimization, (B) post-implant, fi nal dose distribution 
calculated for “real” catheter positions and re-optimized for new implant geometry.
A B
Figure 2. The diff erence between “virtual” and “real” needle 
position r in mm measured on the selected axial image defi ne 
needle displacement.
Figure 3. Anatomic plane defi nition. After image acquisition base, 
reference and apex planes are defi ned. Apex refers to the plane that 
intersects the top of the prostate, while the base is the prostate 
plane closest to the bladder wall; reference is the middle and the 
largest cross-section of the gland.
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median needle number was 17.5. Mean pros-
tate volume considered in this experiment was 
29.75cc (±11.9cc). Needle number correspond-
ed with prostate volume. Higher prostate vol-
umes were implanted with higher needle number 
(Figure 4.)
Mean value of the needle displacement r (Figure 2) 
calculated for thirty “live” treatment plans was 
1.8mm (±0.6 mm) and did not depend on implan-
tation sequence but varied depending on the level 
of transverse imaging: base, apex or reference.
The needle displacement was the smallest for 
the apex and the biggest for the base plane 
(Figure 5).
Analysis of VD parameter
Inﬂ uence of mean needle displacement and pros-
tate volume on the ﬁ nal dose distribution was an-
alyzed with VD parameter (Figure 6).
In the group of treatment plans where VD≤1 
mean value of prostate volume was observed to 
be signiﬁ cantly higher than in the group of VD>1, 
while needle displacement was statistically equal 
in both groups (Table 1).
Changes in dosimetric parameters between virtu-
al and live plan depend on needle displacement 
while prostate volume parameter seems to modu-
late the extent of dose distribution alteration.
In order to obtain a “real” treatment plan at least 
equivalent to the “virtual” one, needle displace-
ments for a given prostate volume are required 
to be equal to or smaller than acceptable, while 
the acceptable values for a mean needle displace-
ment r are assumed to be determined by the ex-
pression:
racceptable(Vp) μ Vp
2 (2)
Where:
Vp – prostate volume in cc by anatomy based con-
touring of PTV performed on the acquired US 
slice before implantation.
racceptable – prescribed maximum acceptable values 
of needle displacement for a given Vp value.
The expression led to the conclusion that for 
smaller glands even slight needle shift from 
Figure 4. Number of implanted needles depends on prostate 
volume Vp parameter. Number of needles and their initial 
coordinates are established with catheter placement option in 
treatment planning system on the basis of contoured patient 
anatomy. “Virtual” needle position and its number can be modifi ed 
manually for better PTV coverage.
Figure 5. Mean needle displacement for consecutive number of 
needle calculated for thirty treatment plans in three axial images. 
The biggest mean needle displacement was observed in the base 
plane of the prostate.
Figure 6. Graph represents the scatter of VD values as a function 
of prostate volume Vp and needle displacement r. The values of 
r(Vp) (solid line on the graph) boundary represent the maximum 
acceptable values of mean needle displacement ra and are relative 
to Vp.
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pre-planned positions may affect essential chang-
es in virtual dose distribution that cannot be re-
duced by re-optimization.
DISCUSSION
Modern imaging techniques such as transrectal ul-
trasounds allow visualization of the procedure of 
implantation and on-line, “real time” evaluation 
of the accuracy of needle positioning according 
to its pre-planned position [7]. Not only for per-
manent seed implants, careful implant prepara-
tion and catheter geometry is an essential part of 
the treatment planning process in brachytherapy 
[8,9]. However, the potential tool of dwell time 
differentiation in HDR stepping source brachy-
therapy can minimize, to a certain degree, the 
superﬂ uous underdosed and overdosed volumes 
resulting from needles’ displacement from their 
pre-planned positions.
The research into the inﬂ uence of an adequate 
needle placement regarding its virtual position as 
a function of prostate volume improves the pos-
sibility of predicting the quality of ﬁ nal dose dis-
tribution at the time of implantation.
Charra-Brunaud et al. [10] suggested that a high-
er number of catheters leads to decreasing values 
of the V150 parameter (percentage of prostate vol-
ume covered with 150% isodose) that allows large 
high-dose volumes inside the PTV to be avoid-
ed. 15 to 21 needles are an adequate number for 
preparing an optimal treatment plan. The results 
seems to be in agreement with our study where 
the number of implanted needles corresponds 
with prostate volume and was in the range of 12 
to 18, which gave sufﬁ cient coverage of PTV by 
reference isodose in the “virtual” treatment plan-
ning phase.
In our study the needle implantation sequence 
was taken into consideration. We assumed that af-
ter implantation of consecutive catheters prostate 
motion would reduce. According to Lagerburg 
et al. [2] the use of locking needles results in 
reduced prostate rotation in the coronal plane 
and thus improves the implantation accuracy. 
However, in our experiment no signiﬁ cant dif-
ferences were observed between needle displace-
ment for ﬁ rst and last implanted needles. Thus, 
during implantation, the prostate movements 
were not reduced by the increasing number of 
implanted needles. Implantation sequence or 
additional locking needles do not inﬂ uence the 
reduction of prostate motion.
The inﬂ uence of mean needle displacement on 
dose distribution depends on prostate volume. 
Changes of the dose distribution calculated for 
bigger gland volume are less dependent on the 
needle shift than for smaller prostates (Figure 4). 
While mean needle displacement is higher than 
2mm, ﬁ nal dose distribution for bigger prostate 
volumes (30cc) can be equivalent or even bet-
ter than virtual when the renewed optimization 
procedure was applied to dose distribution cal-
culated on the basis of “real” implant geometry. 
For prostate volumes lower than 25cc even small 
differences between “virtual” and “real” needle 
positions reduce the effectiveness of optimiza-
tion methods.
If the needle shift exceeds acceptable values for 
a given Vp parameter, determined by ra (Vp) 
function, needle relocation during implantation 
should be considered.
Optimization algorithms are beneﬁ cial for con-
formal treatment planning in brachytherapy but 
their usefulness is restricted by insufﬁ cient im-
plant geometry.
CONCLUSIONS
The calculations demonstrate that ﬁ nal dose dis-
tribution depends on needle displacement, which 
is the distance between “virtual” and “real” nee-
dle position, but prostate volume should be taken 
into consideration. The experiment determined 
maximal values of needle displacement for a giv-
en Vp parameter that still allow one to take ad-
vantage of optimizations algorithms to improve 
the ﬁ nal dose distribution.
VD≤1 n=16 VD>1 n=14
mean ± standard deviation p Mann-Whitney U test
Mean needle displacement r [mm]  1.7±0.46  1.99±0.73 0.28
Prostate volume Vp [cc]  34.25±11.5  24.6±10.45 0.027
Table 1. Diff erences between mean values of geometrical parameters in two groups of VD values.
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However, acceptable values of needle displace-
ment as a function of prostate volume require 
further research and more complex and multi-
factorial analysis.
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